Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways

BACKGROUND: Resveratrol (RSV) has attracted interest as an alternative drug for the treatment of acute lung injury (ALI) and other pulmonary diseases, but its poor oral bioavailability is a limitation. In this study, we employed drug delivery nanotechnology to improve the stability, lung localizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Maria Talita Pacheco, de Sá Coutinho, Diego, Tenório de Souza, Éverton, Stanisçuaski Guterres, Sílvia, Pohlmann, Adriana Raffin, Silva, Patricia Machado Rodrigues, Martins, Marco Aurélio, Bernardi, Andressa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636190/
https://www.ncbi.nlm.nih.gov/pubmed/31371957
http://dx.doi.org/10.2147/IJN.S200666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636190/
https://www.ncbi.nlm.nih.gov/pubmed/31371957
http://dx.doi.org/10.2147/IJN.S200666

Ejemplares similares